Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer clinical trial (NCT02441946). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the treatments be administered, and what should I expect during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer clinical trial (NCT02441946). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of for abemaciclib and anastrozole?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer clinical trial (NCT02441946). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer clinical trial (NCT02441946). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any additional tests or procedures I will need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer clinical trial (NCT02441946). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition changes during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer clinical trial (NCT02441946). Contact the study team or your healthcare provider for specific answers.

What this study is about